David B Cook, MD MPH | |
8330 Allison Pointe Trl, Indianapolis, IN 46250-1682 | |
(317) 284-7672 | |
Not Available |
Full Name | David B Cook |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 8330 Allison Pointe Trl, Indianapolis, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487656385 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
David B Cook, MD MPH 8330 Allison Pointe Trl, Indianapolis, IN 46250-1682 Ph: (317) 284-7672 | David B Cook, MD MPH 8330 Allison Pointe Trl, Indianapolis, IN 46250-1682 Ph: (317) 284-7672 |
News Archive
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
Nursing homes are facing extreme challenges in the midst of the COVID-19 pandemic. Two Regenstrief Institute and Indiana University - including IUPUI - faculty members lay out their case that meaningful partnerships between acute care hospitals and nursing facilities can support better quality of care for people who live in the facilities.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
On Friday afternoon, the Department of Health and Human Services extended the deadline until Dec. 14 for states to submit plans to set up state-based health insurance exchanges under the health care law. Those states that want to partner with the federal government have until Feb. 15 to outline the duties the state government would handle in running the exchanges.
UCB today announced new findings on its antiepileptic drug (AED) VimpatĀ® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking VimpatĀ® for up to three years, and a consistent long-term tolerability profile.
› Verified 9 days ago
Irene A Carrothers, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |